Keyhole vs standard surgery for one small adrenal tumor
Part of Pain clinical trials.
This trial compares two surgical approaches (very small “keyhole” needles versus standard laparoscopic surgery) to remove one adrenal gland tumor under 4 cm. It may help find which method is safer and more comfortable with recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 20 years old (or older than 20).
- You have primary aldosteronism caused by a tumor in one adrenal gland only, and it is smaller than 4 cm.
- Your doctor has determined that laparoscopic surgery is appropriate for you.
- You are able and willing to sign informed consent.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of minimally invasive surgery (laparoscopic vs robotic) to remove an adrenal gland. It aims to see which approach leads to better recovery and outcomes.
This study compares two types of minimally invasive surgery for removing an adrenal gland: laparoscopic (small incisions, using a camera) and robot-assisted (using a robotic arm). It aims to see which approach may be better for recovery and safety.
This study compares two treatments for primary aldosteronism (a condition causing high blood pressure due to an adrenal gland issue). One treatment is a minimally invasive procedure called superselective embolization, and the other is keyhole surgery. This trial aims to see which is better and safer for patients.
This trial compares two ways to treat unilateral primary aldosteronism: taking mineralocorticoid receptor antagonist (MRA) pills or having minimally invasive surgery. It may help decide which option works best and is safest for people who can choose surgery.
This trial compares two treatments—ultrasound-guided ablation and laparoscopic adrenalectomy—for a type of adrenal tumor called aldosterone-producing adenoma (APA) that causes high blood pressure and low potassium. The goal is to see which treatment works better for patients with a single, non-cancerous tumor.
This study tests whether a steroid medication (hydrocortisone) after adrenal gland surgery helps protect kidney function in patients with primary aldosteronism and mild-to-moderate kidney disease. Researchers want to see if the steroid reduces further kidney damage.
Hear when a new Post Operative Pain, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.